Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Exp Med. Mar 20, 2025; 15(1): 99516
Published online Mar 20, 2025. doi: 10.5493/wjem.v15.i1.99516
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Runt-related transcription factor-1 in patients with acute myeloid leukemia. A: Runt-related transcription factor-1 (RUNX1) gene alterations in acute myeloid leukemia (AML) cases; B: G-banded karyotype of a case of t (1; 21). 48, XY, +X, t (1; 21) (p36; q22), +8; C: Interphase fluorescence in situ hybridization using RUNX1 break apart probe showing a split of RUNX1 signal; D: Metaphase fluorescence in situ hybridization using a RUNX1 break apart probe showing a split of the RUNX1 signal. The magnification factor is × 63.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Kaplan-Meier survival curves. A: Runt-related transcription factor-1 (RUNX1) abnormality; B: RUNX1 amplification; C: RUNX1 translocation; D: RUNX1 deletion on overall survival rates in acute myeloid leukemia patients.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Kaplan-Meier survival curves. A: Runt-related transcription factor-1 (RUNX1) abnormality; B: RUNX1 amplification; C: RUNX1 translocation; D: RUNX1 deletion on disease-free survival of patients with adult acute myeloid leukemia.